arrow
D

Donald C. McMillan

department of surgery
H指数:103
被引数:4.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal‑rich

纠正:JAK/STAT3是富基质结直肠癌患者的治疗靶点

2026-08-150
OAAI
The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantation

系统性炎症反应测量作为异基因造血细胞移植后结局的移植前风险因素的重要性

2025-07-290
OA
The Global Leadership Initiative on Malnutrition (GLIM) inflammation criteria to predict survival in patients with advanced cancer: A prospective cohort study

全球营养不良领导倡议(GLIM)炎症标准在预测晚期癌症患者生存中的应用:一项前瞻性队列研究

2025-06-010
OAAI
Dissecting the global leadership initiative on malnutrition criteria in advanced cancer: Reduced intake vs. inflammation

剖析全球领导力倡议中针对晚期癌症营养不良标准的探讨:摄入减少与炎症

2025-06-010
OAAI
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
2024-05-234
OA
Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series

癌症恶病质临床试验中的体重及身体成分终点:恶病质终点系列之系统综述第4篇

2024-05-132
OAAI
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors
2024-03-018
OAAI
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
2023-09-0616
OAAI